Trademarkia Logo

Canada

C$
SAGA DIAGNOSTICS
REGISTERED

on 1 Mar 2023

Last Applicant/ Owned by

SAGA DIAGNOSTICS AB

Medicon Village,Scheelevägen 2SE-223 81 Lund

SE

Serial Number

2058946 filed on 5th Mar 2020

Registration Number

TMA1168295 registered on 1st Mar 2023

Registration expiry Date

5th Mar 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

SAGA DIAGNOSTICS

Trademark usage description

biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of Read More

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

26 . 4 . 2

RectanglesRectangles

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 12

Letters or numerals representing a heavenly body or a natural phenomenonLettres ou chiffres représentant un corps céleste ou un phénomène naturel

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 4

BlueBleu

29 . 1 . 8

BlackNoir

Classification Information


Class [005]
Biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; botanicals for the treatment of cancer; herbal supplements for the treatment of cancer; herbal pills for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; chemical preparations for use in DNA analysis [medical]; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the prevention of tumours; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; nucleic acid sequences in the form of oligonucleotides for diagnosing and monitoring cancer; medical diagnostic reagents and assays for testing of body fluids; clinical diagnostic reagents; veterinary diagnostic reagents; medical diagnostic reagents; genetic identity tests comprised of reagents for medical purposes; drug testing kits comprising primarily medical diagnostic reagents and assays for testing body fluids; genetic identity tests comprised of reagents for medical purposes; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; diagnostic preparations for medical laboratory use; reagents for use in diagnostic pregnancy tests for veterinary purposes; reagents for use in diagnostic tests for veterinary purposes; diagnostic reagents for medical use; diagnostic reagents for medicinal use; immunoassay reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; chemical diagnostic reagents for medical use; reagents for blood grouping [for medical purposes]; reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; reagents for use in diagnostic pregnancy tests; diagnostic chemical reagents for medical purposes; diagnostic reagents for medical purposes; diagnostic test reagents for medical purposes; reagents for use in diagnostic pregnancy tests for medical purposes; reagents for use in diagnostic tests for medical purposes; reagent paper for medical and veterinary purposes; reagents for use in diagnostic tests [for medical purposes]; reagents for use in diagnostic tests [for veterinary purposes]; in vitro diagnostic preparations for medical purposes; in vitro diagnostic preparations for veterinary purposes; genetic identity tests comprised of reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; reagents for use in veterinary genetic testing; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes.


Classification kind code

11

Class [042]
Scientific research for medical purposes in the area of cancerous diseases; veterinary laboratory services; chemical laboratory services; biological laboratory services; medical research laboratory services; chemical research laboratory services; biological research laboratory services; services of a chemical laboratory; DNA testing services to determine paternity (laboratory services); laboratory research services relating to dermatology; laboratory research services relating to pharmaceuticals; laboratory services relating to the production of monoclonal antibodies; DNA screening for scientific research purposes; clinical trials; conducting clinical trials; clinical trials (conducting); conducting clinical trials for pharmaceutical products; conducting clinical trials in the field of cardiovascular disease; conducting clinical trials in the field of acupuncture therapy; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical research; biological research, clinical research and medical research; basic and clinical research in the field of respiratory science and medicine; pharmaceutical research services; research of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical research and development services; laboratory research services relating to pharmaceuticals; research on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; research and development in the field of biochemistry and biotechnology; genetic fingerprinting; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; genetic testing for scientific research purposes; genetic engineering services relating to plants; research in the field of gene therapy; scientific research relating to genetics of plants; laboratory research in the field of gene expression; genetic testing of laboratory animals for research


Classification kind code

11

Class [044]
Lung cancer screening services; prostate cancer screening services; breast cancer screening services; bowel cancer screening services; cervical cancer screening services; providing cancer screening services; testicular cancer screening services; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of samples taken from patients; medical laboratory services for the analysis of blood samples taken from patients; medical analysis services relating to the treatment of persons provided by a medical laboratory; DNA screening for medical purposes; drug, alcohol and DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; genetic counseling; genetic testing of animals; genetic testing for medical purposes; genetic testing of animals for diagnostic or treatment purposes.


Classification kind code

11

Mark Details


Serial Number

2058946

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 31st Jan 2022
Agent Changed
Submitted for opposition 22
on 18th Oct 2021
Search Recorded
Submitted for opposition 20
on 18th Oct 2021
Examiner's First Report
Submitted for opposition 223
on 18th Oct 2021
Total Provisional Refusal
Submitted for opposition 256
on 23rd Aug 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 22nd Oct 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 22nd Oct 2020
Formalized
Submitted for opposition 1
on 21st Oct 2020
Created
Submitted for opposition 228
on 5th Mar 2020
International Registration
Submitted for opposition 30
on 5th Mar 2020
Filed